DelveInsight launched its new report on Acne Vulgaris (AV) – Market Insights, Epidemiology, and Market Forecast-2030
DelveInsight’s “Acne Vulgaris (AV) Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acne Vulgaris (AV), historical and forecasted epidemiology as well as the Acne Vulgaris (AV) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some key facts of the report:
1. Acne Vulgaris affects ~85% of young adults aged 12–25 years.
2. Acne vulgaris is more common in males than in females.
Key benefits of the report:
1. In the coming years, Acne Vulgaris (AV) market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
2. The companies and academics are working to assess challenges and seek opportunities that could influence Acne Vulgaris (AV) R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
3. Major players are involved in developing therapies for Acne Vulgaris (AV) . Launch of emerging therapies will significantly impact the Acne Vulgaris (AV) market
4. A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Acne Vulgaris (AV)
Acne Vulgaris (AV) is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland).
Moderate-to-severe inflammatory acne is characterized by the presence of nodules and cyst.
Request for sample pages: https://www.delveinsight.com/sample-request/acne-vulgaris-av-market
Key pharma players involved in Acne Vulgaris market are:
- Maruho
- Boston Pharmaceuticals
- Botanix Pharmaceuticals
- Vyome
- Novartis Pharmaceuticals
Drugs involved are:
- CLS001
- BOS-356
- BTX 1503
- VB-1953
- LYS006
Table of contents:
1. Key Insights
2. Executive Summary of Acne Vulgaris (AV)
3. Competitive Intelligence Analysis for Acne Vulgaris (AV)
4. Acne Vulgaris (AV) : Market Overview at a Glance
5. Acne Vulgaris (AV) : Disease Background and Overview
6. Patient Journey
7. Acne Vulgaris (AV) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Acne Vulgaris (AV) Treatment
11. Marketed Products
12. Emerging Therapies
13. Acne Vulgaris (AV) : Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Acne Vulgaris (AV)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Related reports:
Acne Vulgaris Pipeline Insight, 2020
Acne Vulgaris – Epidemiology Forecast to 2030
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/